Hence, impaired insulin and IGF-1 signaling resulting in decreased GSK-3β (Ser 9) expression allows for phosphorylation of p-GSK-3β, a potent phosphorylating stress kinase, which has also been implicated in Alzheimer-like changes in diabetes [51]. Here, IGF1 is linked to diabetes mellitus.